Not applicableEnded earlyNCT05926544What this trial is testingCOVID-19 Vaccine Hesitancy Counseling Intervention for PharmacistsWho this might be right forCOVID-19 University of North Carolina, Chapel Hill 16
Post-approval studies (Phase 4)UnknownNCT05075044What this trial is testingImmunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV InfectedWho this might be right forHIV InfectionsCOVID-19 China National Biotec Group Company Limited 400
Testing effectiveness (Phase 2)Study completedNCT05727215What this trial is testingHeterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of AgeWho this might be right forCOVID-19 PT Bio Farma 150
Not applicableUnknownNCT05745545What this trial is testingClinical Trial of COVID-19 Vaccine(SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine) in Participants Aged 18 Years and OverWho this might be right forSARS-CoV-2 AIM Vaccine Co., Ltd. 3,200
Testing effectiveness (Phase 2)UnknownNCT05172193What this trial is testingSafety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)Who this might be right forCOVID-19 PT. Kimia Farma (Persero) Tbk 600
Testing effectiveness (Phase 2)Study completedNCT04695652What this trial is testingEvaluate MVC-COV1901 Vaccine Against COVID-19 in AdultWho this might be right forCovid19 Vaccine Medigen Vaccine Biologics Corp. 3,854
Not applicableUnknownNCT05429047What this trial is testingPriming of the NEonatal Immune System by Transfer of Maternal ImmunityWho this might be right forCOVID-19Maternal Vaccine ExposureRespiratory Infections in Children Hannover Medical School 560
Large-scale testing (Phase 3)WithdrawnNCT04683224What this trial is testingEvaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 VaccineWho this might be right forCovid-19SARS-CoV-2Coronavirus Vaxxinity, Inc.
Post-approval studies (Phase 4)Study completedNCT05398926What this trial is testingImmunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the ElderlyWho this might be right forCOVID-19 Sinovac Life Sciences Co., Ltd. 400
Not applicableLooking for participantsNCT05869968What this trial is testingSCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCIWho this might be right forSpinal Cord InjuriesTraumatic Spinal Cord InjuryHealthy Controls+2 more Northwell Health 140
Not applicableStudy completedNCT04858568What this trial is testingImmune Responses to COVID-19 Vaccination in Lymphoma PatientsWho this might be right forClassical Hodgkin LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal B Cell Lymphoma+10 more University Hospital Southampton NHS Foundation Trust 592
Large-scale testing (Phase 3)Study completedNCT04927065What this trial is testingEvaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) VariantsWho this might be right forSARS-CoV-2 ModernaTX, Inc. 5,161
Not applicableLooking for participantsNCT06070961What this trial is testingProspective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 MaintenanceWho this might be right forFollicular Lymphoma Fondazione Italiana Linfomi - ETS 56
Early research (Phase 1)UnknownNCT04885361What this trial is testingTo Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy AdultsWho this might be right forCoronavirus Disease (COVID-19) OSE Immunotherapeutics 48
Not applicableActive Not RecruitingNCT05449418What this trial is testingEngaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care FacilitiesWho this might be right forCOVID-19 Kaiser Permanente 988
Not applicableUnknownNCT05258760What this trial is testingCovid 19 Vaccine Acceptance in Egyptian Pregnant WomenWho this might be right forCOVID-19 Cairo University 1,100
Testing effectiveness (Phase 2)Study completedNCT04895982What this trial is testingStudy to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 YearsWho this might be right forSARS-CoV-2 Infection, COVID19 BioNTech SE 124
Large-scale testing (Phase 3)Study completedNCT04917523What this trial is testingImmuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and AboveWho this might be right forCOVID-19 PneumoniaCOVID-19 China National Biotec Group Company Limited 1,800
Early research (Phase 1)Study completedNCT05148962What this trial is testingStudy of GRT-R910 COVID-19 Boost Vaccine in Healthy VolunteersWho this might be right forCOVID-19 Gritstone bio, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT04930003What this trial is testingReactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 VaccineWho this might be right forCovid19SARS-CoV InfectionVaccine Adverse Reaction Research Institute for Biological Safety Problems 244